Cimerli
Payments companies reported to CMS as associated with Cimerli. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cimerli, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cimerli
These are the largest totals companies reported as associated with Cimerli. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dilsher Dhoot | Santa Barbara, CA | Retina Specialist | $126,009.27 |
| Seenu Hariprasad | Chicago, IL | Ophthalmology | $91,380.19 |
| Michael Singer | San Antonio, TX | Ophthalmology | $83,860.73 |
| Daniel Kiernan | Sarasota, FL | Ophthalmology | $80,077.92 |
| Rishi Singh | Boston, MA | Ophthalmology | $38,514.55 |
| Michael Klufas | Plymouth Meeting, PA | Ophthalmology | $17,342.38 |
| Baruch Kuppermann | Irvine, CA | Retina Specialist | $16,011.90 |
| Firas Rahhal | Los Angeles, CA | Ophthalmology | $15,859.39 |
| John Huang | Hartford, CT | Ophthalmology | $14,697.38 |
| Todd Schneiderman | Silverdale, WA | Ophthalmology | $13,775.09 |
Prescribed Cimerli?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.